Physician profile
Brenda E Mitchell
NPI 1750836219
$5,265.05
in general payments reported to CMS, 2019-2025
13 companies · $72.80 in 2025
The $72.80 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,209 · 2022: $1,197 · 2023: $2,010 · 2024: $777 · 2025: $72.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,859.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $2,013.30 | 2022-2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $889.32 | 2021-2025 | Lifevest |
| Abbott Laboratories | $436.83 | 2022 | |
| Boston Scientific Corporation | $383.21 | 2021-2023 | Watchman Access System |
| Amgen INC. | $345.80 | 2021-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.31 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $270.11 | 2021-2022 | |
| Abiomed | $238.20 | 2023-2024 | Impella |
| Edwards Lifesciences Corporation | $132.12 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $121.83 | 2023 | Evkeeza |
| Merck Sharp & Dohme LLC | $74.65 | 2021 | |
| Janssen Pharmaceuticals, INC | $46.60 | 2023 | Xarelto |
| Abbvie INC. | $18.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.